Novo to track generic surge as semaglutide goes off patentNovo Nordisk is preparing for a surge of generic semaglutide drugs in India. The company's India head stated they will monitor rivals' pric...
Intense Lilly, Novo rivalry throws India weight-loss drug race wide openEli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outre...
Novo Nordisk bets on cheaper Ozempic to dominate India’s booming weight-loss marketNovo Nordisk has launched Ozempic in India at a competitive price, aiming to capture a significant share of the growing weight-loss market....
Novo Nordisk India partners with Healthify to launch AI-enabled patient support programmeNovo Nordisk India and Healthify have launched a new programme. It offers AI-assisted lifestyle guidance for people with obesity. This part...
Novo Nordisk India prioritises patient outcomes; revenue growth follows naturally, says ShrotriyaNovo Nordisk India head Vikrant Shrotriya revealed a strategic 37% price cut for obesity drug Wegovy, aiming for wider accessibility. The c...
Patent expiry looms: Eli Lilly and Novo Nordisk strategise to defend their top obesity drugs in IndiaAt a recent industry summit, executives from Eli Lilly and Novo Nordisk unveiled their game plan for tackling weight-loss medications in In...
Novo, Emcure to launch weight-loss drug under new brand in IndiaIn June, Novo Nordisk launched Wegovy (semaglutide) injections in five dosing strengths (0.25, 0.5, 1, 1.7 and 2.4 mg). However, the compan...
IIM Ahmedabad, Novo Nordisk India partner to strengthen obesity care ecosystemThe Indian Institute of Management Ahmedabad (IIMA) and Novo Nordisk India have partnered to strengthen India's obesity care ecosystem. The...
Novo Nordisk’s Wegovy enters India: Can this weight loss jab beat Mounjaro? Price, who can use it & how it worksNovo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy conta...
Karnataka govt to drop 495 acres from hi-tech aerospace park plan after protestsThe land is situated across three villages in Channarayapatna hobli in the Bengaluru rural district. Local farmers have been on a protest s...
Novo Nordisk aims for heavy sales in India with WegovyThe achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescriptio...
Novo Nordisk not yet ready to bring in popular obesity, diabetes injectablesNovo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The company is scali...
Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycatsNovo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure suff...
7-yr-old girl becomes an author, pens book 'The Dark Firefly' on inclusivity & identityWith her book, Parnika Shrotriya wants to encourage children to celebrate their uniqueness.
Novo Nordisk launches anti-diabetes pill semaglutide in IndiaNovo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
Windies legend Brian Lara hospitalised due to chest pain, could be discharged soonBesides his countless fans, Cricket West Indies (CWI) wished him a speedy recovery.
Wi-Fi facilities at old Ghaziabad bus stand from May 20The Uttar Pradesh roadways will soon offer Wi-Fi facilities for its passengers at old bus stand of Ghaziabad.